Cytolethal Distending Toxins Require Components of the ER-Associated Degradation Pathway for Host Cell Entry

English version České info

Cytolethal distending toxins (CDTs) are produced by several bacterial pathogens and increase the ability of these bacteria to cause disease. After being taken up by host cells, CDTs are trafficked to the endoplasmic reticulum (ER) where they must translocate across the ER membrane to gain access to their intracellular target; however, this translocation process is poorly understood for CDTs. Here we provide evidence that CDTs require components of the ER-associated degradation (ERAD) pathway, a normal cellular process utilized to translocate terminally misfolded ER lumenal and membrane proteins across the ER membrane for degradation in the cytosol. Deletion of a key member of this pathway, Derl2, makes cells resistant to multiple CDTs. Interestingly, two domains within Derl2 which are required for ERAD of misfolded proteins are dispensable for intoxication by CDT. Further, we report two previously uncharacterized domains within Derl2 that are each required for intoxication. Consistent with a role of Derl2, abrogation of two other members of the ERAD pathway, Hrd1 and p97, results in retention of CDT in the ER and resistance to intoxication. Taken together, these data provide novel insight into how CDTs exit the ER and therefore gain access to their cellular targets.

Vyšlo v časopise: Cytolethal Distending Toxins Require Components of the ER-Associated Degradation Pathway for Host Cell Entry. PLoS Pathog 10(7): e32767. doi:10.1371/journal.ppat.1004295
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004295

Souhrn

Zdroje

1. AhmedHJ, SvenssonLA, CopeLD, LatimerJL, HansenEJ, et al. (2001) Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol 50: 860–864.

2. McAuleyJL, LindenSK, PngCW, KingRM, PenningtonHL, et al. (2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117: 2313–2324.

3. YoungVB, KnoxKA, PrattJS, CortezJS, MansfieldLS, et al. (2004) In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 72: 2521–2527.

4. FoxJG, RogersAB, WharyMT, GeZ, TaylorNS, et al. (2004) Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72: 1116–1125.

5. PurdyD, BuswellCM, HodgsonAE, McAlpineK, HendersonI, et al. (2000) Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. J Med Microbiol 49: 473–479.

6. GeZ, RogersAB, FengY, LeeA, XuS, et al. (2007) Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 9: 2070–2080.

7. GeZ, FengY, WharyMT, NambiarPR, XuS, et al. (2005) Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 73: 3559–3567.

8. GargiA, RenoM, BlankeSR (2012) Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally? Front Cell Infect Microbiol 2: 124.

9. ShenkerBJ, HoffmasterRH, ZekavatA, YamaguchiN, LallyET, et al. (2001) Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J Immunol 167: 435–441.

10. PickettCL, WhitehouseCA (1999) The cytolethal distending toxin family. Trends Microbiol 7: 292–297.

11. GuidiR, GuerraL, LeviL, StenerlowB, FoxJG, et al. (2013) Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell Microbiol 15: 98–113.

12. GuerraL, Cortes-BrattiX, GuidiR, FrisanT (2011) The biology of the cytolethal distending toxins. Toxins (Basel) 3: 172–190.

13. ThelestamM, FrisanT (2004) Cytolethal distending toxins. Rev Physiol Biochem Pharmacol 152: 111–133.

14. BlankeSR (2006) Portals and Pathways: Principles of Bacterial Toxin Entry into Host Cells. Microbe 1: 26–32.

15. ElwellCA, DreyfusLA (2000) DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 37: 952–963.

16. Lara-TejeroM, GalanJE (2000) A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290: 354–357.

17. McSweeneyLA, DreyfusLA (2005) Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect Immun 73: 2051–2060.

18. CaoL, BandelacG, VolginaA, KorostoffJ, DiRienzoJM (2008) Role of aromatic amino acids in receptor binding activity and subunit assembly of the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans. Infect Immun 76: 2812–2821.

19. CaoL, VolginaA, HuangCM, KorostoffJ, DiRienzoJM (2005) Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol Microbiol 58: 1303–1321.

20. NesicD, StebbinsCE (2005) Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT. PLoS Pathog 1: e28.

21. GargiA, TamilselvamB, PowersB, ProutyMG, LincecumT, et al. (2013) Cellular interactions of the cytolethal distending toxins from escherichia coli and haemophilus ducreyi. J Biol Chem 288(11): 7492–505.

22. GuerraL, TeterK, LilleyBN, StenerlowB, HolmesRK, et al. (2005) Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 7: 921–934.

23. SpoonerRA, WatsonPD, MarsdenCJ, SmithDC, MooreKA, et al. (2004) Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem J 383: 285–293.

24. DayPJ, OwensSR, WescheJ, OlsnesS, RobertsLM, et al. (2001) An interaction between ricin and calreticulin that may have implications for toxin trafficking. J Biol Chem 276: 7202–7208.

25. Slominska-WojewodzkaM, GregersTF, WalchliS, SandvigK (2006) EDEM is involved in retrotranslocation of ricin from the endoplasmic reticulum to the cytosol. Mol Biol Cell 17: 1664–1675.

26. MoreauD, KumarP, WangSC, ChaumetA, ChewSY, et al. (2011) Genome-wide RNAi screens identify genes required for Ricin and PE intoxications. Dev Cell 21: 231–244.

27. LiS, SpoonerRA, AllenSC, GuiseCP, LaddsG, et al. (2010) Folding-competent and folding-defective forms of ricin A chain have different fates after retrotranslocation from the endoplasmic reticulum. Mol Biol Cell 21: 2543–2554.

28. RedmannV, OresicK, TortorellaLL, CookJP, LordM, et al. (2011) Dislocation of ricin toxin A chains in human cells utilizes selective cellular factors. J Biol Chem 286: 21231–21238.

29. SimpsonJC, RobertsLM, RomischK, DaveyJ, WolfDH, et al. (1999) Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Lett 459: 80–84.

30. BernardiKM, ForsterML, LencerWI, TsaiB (2008) Derlin-1 facilitates the retro-translocation of cholera toxin. Mol Biol Cell 19: 877–884.

31. DixitG, MikoryakC, HayslettT, BhatA, DraperRK (2008) Cholera toxin up-regulates endoplasmic reticulum proteins that correlate with sensitivity to the toxin. Exp Biol Med (Maywood) 233: 163–175.

32. HebertDN, BernasconiR, MolinariM (2010) ERAD substrates: which way out? Semin Cell Dev Biol 21: 526–532.

33. JaroschE, TaxisC, VolkweinC, BordalloJ, FinleyD, et al. (2002) Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol 4: 134–139.

34. RabinovichE, KeremA, FrohlichKU, DiamantN, Bar-NunS (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 22: 626–634.

35. YeY, ShibataY, YunC, RonD, RapoportTA (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429: 841–847.

36. TeterK, HolmesRK (2002) Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect Immun 70: 6172–6179.

37. GuerraL, NemecKN, MasseyS, TatulianSA, ThelestamM, et al. (2009) A novel mode of translocation for cytolethal distending toxin. Biochim Biophys Acta 1793: 489–495.

38. Damek-PoprawaM, JangJY, VolginaA, KorostoffJ, DiRienzoJM (2012) Localization of Aggregatibacter actinomycetemcomitans cytolethal distending toxin subunits during intoxication of live cells. Infect Immun 80: 2761–2770.

39. McSweeneyLA, DreyfusLA (2004) Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol 6: 447–458.

40. NishikuboS, OharaM, UenoY, IkuraM, KuriharaH, et al. (2003) An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 278: 50671–50681.

41. CaretteJE, GuimaraesCP, VaradarajanM, ParkAS, WuethrichI, et al. (2009) Haploid genetic screens in human cells identify host factors used by pathogens. Science 326: 1231–1235.

42. CaretteJE, GuimaraesCP, WuethrichI, BlomenVA, VaradarajanM, et al. (2011) Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol 29: 542–546.

43. StrausbergRL, FeingoldEA, KlausnerRD, CollinsFS (1999) The mammalian gene collection. Science 286: 455–457.

44. BanksDJ, BradleyKA (2007) SILENCE: a new forward genetic technology. Nat Methods 4: 51–53.

45. MaliP, YangL, EsveltKM, AachJ, GuellM, et al. (2013) RNA-guided human genome engineering via Cas9. Science 339: 823–826.

46. DangH, KlokkTI, SchaheenB, McLaughlinBM, ThomasAJ, et al. (2011) Derlin-dependent retrograde transport from endosomes to the Golgi apparatus. Traffic 12: 1417–1431.

47. HuangCH, HsiaoHT, ChuYR, YeY, ChenX (2013) Derlin2 facilitates HRD1-mediated retro-translocation of sonic hedgehog at the endoplasmic reticulum. J Biol Chem 288(35): 25330–9.

48. LilleyBN, PloeghHL (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429: 834–840.

49. GreenblattEJ, OlzmannJA, KopitoRR (2011) Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant alpha-1 antitrypsin from the endoplasmic reticulum. Nat Struct Mol Biol 18: 1147–1152.

50. YeY, MeyerHH, RapoportTA (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414: 652–656.

51. DeLaBarreB, ChristiansonJC, KopitoRR, BrungerAT (2006) Central pore residues mediate the p97/VCP activity required for ERAD. Mol Cell 22: 451–462.

52. WangY, ZhangY, HaY (2006) Crystal structure of a rhomboid family intramembrane protease. Nature 444: 179–180.

53. WuZ, YanN, FengL, ObersteinA, YanH, et al. (2006) Structural analysis of a rhomboid family intramembrane protease reveals a gating mechanism for substrate entry. Nat Struct Mol Biol 13: 1084–1091.

54. SandvigK, van DeursB (2005) Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther 12: 865–872.

55. LilleyBN, GilbertJM, PloeghHL, BenjaminTL (2006) Murine polyomavirus requires the endoplasmic reticulum protein Derlin-2 to initiate infection. J Virol 80: 8739–8744.

56. MeyerH, BugM, BremerS (2012) Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol 14: 117–123.

57. EshraghiA, Maldonado-ArochoFJ, GargiA, CardwellMM, ProutyMG, et al. (2010) Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J Biol Chem 285: 18199–18207.

58. BradleyKA, MogridgeJ, MourezM, CollierRJ, YoungJA (2001) Identification of the cellular receptor for anthrax toxin. Nature 414: 225–229.

59. GibsonDG, YoungL, ChuangRY, VenterJC, HutchisonCA3rd, et al. (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6: 343–345.